114 related articles for article (PubMed ID: 18637945)
1. Huntington's disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription.
Bhattacharyya NP; Banerjee M; Majumder P
FEBS J; 2008 Sep; 275(17):4271-9. PubMed ID: 18637945
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in cells expressing exogenous Hippi, a molecular partner of huntingtin-interacting protein Hip1.
Majumder P; Chattopadhyay B; Mazumder A; Das P; Bhattacharyya NP
Neurobiol Dis; 2006 May; 22(2):242-56. PubMed ID: 16364650
[TBL] [Abstract][Full Text] [Related]
3. BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis.
Gdynia G; Lehmann-Koch J; Sieber S; Tagscherer KE; Fassl A; Zentgraf H; Matsuzawa S; Reed JC; Roth W
Apoptosis; 2008 Mar; 13(3):437-47. PubMed ID: 18188704
[TBL] [Abstract][Full Text] [Related]
4. Striatal specificity of gene expression dysregulation in Huntington's disease.
Thomas EA
J Neurosci Res; 2006 Nov; 84(6):1151-64. PubMed ID: 16983659
[TBL] [Abstract][Full Text] [Related]
5. Rybp interacts with Hippi and enhances Hippi-mediated apoptosis.
Stanton SE; Blanck JK; Locker J; Schreiber-Agus N
Apoptosis; 2007 Dec; 12(12):2197-206. PubMed ID: 17874297
[TBL] [Abstract][Full Text] [Related]
6. Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes.
Majumder P; Choudhury A; Banerjee M; Lahiri A; Bhattacharyya NP
FEBS J; 2007 Aug; 274(15):3886-99. PubMed ID: 17623017
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression, purification, crystallization and preliminary crystallographic analysis of pseudo death-effector domain of HIPPI, a molecular partner of Huntingtin-interacting protein HIP-1.
Banerjee M; Majumder P; Bhattacharyya NP; Dattagupta JK; Sen U
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Dec; 62(Pt 12):1247-50. PubMed ID: 17142908
[TBL] [Abstract][Full Text] [Related]
8. [The role of mitochondria in the pathogenesis of Huntington's disease].
Karachitos A; Gałgańska H; Kmita H
Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
[TBL] [Abstract][Full Text] [Related]
9. Huntington's disease: the current state of research with peripheral tissues.
Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: Histone modifications in Huntington's disease.
Sadri-Vakili G; Cha JH
Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
[TBL] [Abstract][Full Text] [Related]
11. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.
Gervais FG; Singaraja R; Xanthoudakis S; Gutekunst CA; Leavitt BR; Metzler M; Hackam AS; Tam J; Vaillancourt JP; Houtzager V; Rasper DM; Roy S; Hayden MR; Nicholson DW
Nat Cell Biol; 2002 Feb; 4(2):95-105. PubMed ID: 11788820
[TBL] [Abstract][Full Text] [Related]
12. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
Browne SE
Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
Bantubungi K; Blum D
Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI).
Niu Q; Ybe JA
J Mol Biol; 2008 Feb; 375(5):1197-205. PubMed ID: 18155047
[TBL] [Abstract][Full Text] [Related]
16. Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1.
Banerjee M; Datta M; Majumder P; Mukhopadhyay D; Bhattacharyya NP
Nucleic Acids Res; 2010 Jan; 38(3):878-92. PubMed ID: 19934260
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology of Huntington's disease: an update].
Roze E; Betuing S; Deyts C; Vidailhet M; Caboche J
Rev Neurol (Paris); 2008 Dec; 164(12):977-94. PubMed ID: 18808762
[TBL] [Abstract][Full Text] [Related]
18. Regulation of intracellular HAP1 trafficking.
Rong J; Li SH; Li XJ
J Neurosci Res; 2007 Nov; 85(14):3025-9. PubMed ID: 17474105
[TBL] [Abstract][Full Text] [Related]
19. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.
Schneider SA; Walker RH; Bhatia KP
Nat Clin Pract Neurol; 2007 Sep; 3(9):517-25. PubMed ID: 17805246
[TBL] [Abstract][Full Text] [Related]
20. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients.
Almeida S; Sarmento-Ribeiro AB; Januário C; Rego AC; Oliveira CR
Biochem Biophys Res Commun; 2008 Oct; 374(4):599-603. PubMed ID: 18625199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
